LIVE Symposium
September 17-18, 2025
10:00 AM – 2:00 PM ET
Adeno-associated viruses (AAVs) have emerged as essential tools for delivering genetic material into tissues and engineering therapeutic cells. As gene and cell therapies advance, researchers optimize AAV design and enhance vector production to improve targeting, precision, and safety.
In this two-day symposium hosted by The Scientist, experts will discuss the latest advancements, practical applications, and ongoing challenges related to the use of AAVs in cell and gene therapy.
Topics to be covered
Investigating AAV serotype tropism in vivo using fluorescent reporter mouse models
Defining the minimal adenoviral helper gene set for improved AAV production and safety
Exploring AAV-based immunomodulation to prevent transplant rejection
Developing enhancer-driven AAV vectors for targeted gene expression in the brain
Strategies for optimizing chemically defined media for scalable AAV production
Bill Lagor, PhD
Kyle and Josephine Morrow Endowed Professor
Department of Integrative Physiology
Baylor College of Medicine
Nerea Zabaleta, PhD
Researcher
Centre for Applied Medical Research
University of Navarra
Matt Hirsch, PhD
Associate Professor
Department of Ophthalmology
University of North Carolina at Chapel Hill
Xiangmin Xu, PhD
Chancellor’s Professor
Department of Anatomy and Neurobiology
University of California, Irvine
Hirotaka Kuroda, PhD
R&D Engineer
Shimadzu Corporation
Platinum Sponsors
Gold Sponsors
Silver Sponsors
